New York State Common Retirement Fund’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11
| Closed | – | – | 3198 |
|
|
2024
Q2 | $0 | Sell |
11
-6
| -35% | – | ﹤0.01% | 3344 |
|
|
2024
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 3227 |
|
|
2023
Q4 | $1K | Sell |
17
-2
| -11% | -$118 | ﹤0.01% | 3241 |
|
|
2023
Q3 | $1K | Sell |
19
-665
| -97% | -$35K | ﹤0.01% | 3260 |
|
|
2023
Q2 | $73K | Buy |
684
+4
| +0.6% | +$427 | ﹤0.01% | 3031 |
|
|
2023
Q1 | $203K | Sell |
680
-43
| -6% | -$12.8K | ﹤0.01% | 2578 |
|
|
2022
Q4 | $249K | Sell |
723
-1
| -0.1% | -$344 | ﹤0.01% | 2633 |
|
|
2022
Q3 | $137K | Buy |
724
+4
| +0.6% | +$757 | ﹤0.01% | 2908 |
|
|
2022
Q2 | $152K | Sell |
720
-2
| -0.3% | -$422 | ﹤0.01% | 2911 |
|
|
2022
Q1 | $241K | Sell |
722
-1
| -0.1% | -$334 | ﹤0.01% | 2753 |
|
|
2021
Q4 | $235K | Buy |
723
+1
| +0.1% | +$325 | ﹤0.01% | 2808 |
|
|
2021
Q3 | $351K | Sell |
722
-235
| -25% | -$114K | ﹤0.01% | 2658 |
|
|
2021
Q2 | $445K | Sell |
957
-422
| -31% | -$196K | ﹤0.01% | 2664 |
|
|
2021
Q1 | $953K | Buy |
1,379
+635
| +85% | +$439K | ﹤0.01% | 2148 |
|
|
2020
Q4 | $550K | Buy |
744
+138
| +23% | +$102K | ﹤0.01% | 2308 |
|
|
2020
Q3 | $421K | Hold |
606
| – | – | ﹤0.01% | 2288 |
|
|
2020
Q2 | $514K | Buy |
606
+212
| +54% | +$180K | ﹤0.01% | 2186 |
|
|
2020
Q1 | $141K | Sell |
394
-181
| -31% | -$64.8K | ﹤0.01% | 2628 |
|
|
2019
Q4 | $134K | Hold |
575
| – | – | ﹤0.01% | 2909 |
|
|
2019
Q3 | $65K | Hold |
575
| – | – | ﹤0.01% | 3123 |
|
|
2019
Q2 | $101K | Buy |
+575
| New | +$101K | ﹤0.01% | 3100 |
|